期刊文献+

线粒体铰链蛋白在肝细胞肝癌组织中的表达及其临床意义

Mitochondrial Hinge Protein Expression and Its Clinical Significance in Hepatocellular Carcinoma
下载PDF
导出
摘要 目的:研究线粒体铰链蛋白在肝细胞肝癌(HCC)组织中的表达及其临床意义,并对线粒体铰链蛋白与肝癌的恶性行为之间关系进行研究。方法:80例HCC、80例癌旁组织和50例正常肝组织标本常规制作石蜡包埋切片,线粒体铰链蛋白染色方法为SP免疫组化法。结果:HCC组织中的线粒体铰链蛋白表达阳性率及其评分明显高于癌旁组织和正常肝组织(P<0.05),而在癌旁组织和正常肝组织之间无显著性差异;线粒体铰链蛋白的蛋白表达与患者的性别、年龄、肝硬化、病理学分级、术前AFP浓度差异无统计学意义(P>0.05),而与肿瘤的大小、癌栓、有无包膜以及TNM分期等差异有统计学意义(P<0.05)。结论:线粒体铰链蛋白的表达与HCC的一些恶性临床病理特征密切相关,提示线粒体铰链蛋白可能是反映HCC发生发展、侵袭、转移的一个重要的生物学指标。 Objective: To study the expression of mitochondrial hinge protein ( MHP ) in hepatocellular carcinoma ( HCC ), to explore its clinicopathologic significance, and to study the relationship between MHP expression and the malignant behavior of HCC. Methods: The SP immunohistochemical method was used to determine MHP expression in paraffin-embedded sections from 80 HCC cases, 80 juxtacancerous specimens, and 50 normal liver tissue samples. Results: The MHP-positive rates and scores were significantly higher in the HCC cases than in the juxtacancerous specimens and normal liver tissues ( P 〈 0.05 ). No significant differences were ob- served between the juxtacancerous specimens and normal paraneoplastic liver tissues ( P 〈 0.05 ). MHP expression was significantly correlated with tumor size and tumor thrombli in the portal vein of HCC ( P 〈 0.05 ), but not with sex, age, liver cirrhosis, or the al- phafetoprotein ( P 〉 0.05 ). Conclusion: MHP expression significantly correlates with the malignant behavior of HCC. This protein may be an important biological marker for the carcinogenesis, tumor progression, biological behavior, and prognosis of HCC.
作者 杨冬 李悦国
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2011年第23期1447-1448,1457,共3页 Chinese Journal of Clinical Oncology
关键词 肝细胞肝癌 线粒体铰链蛋白 免疫组织化学 Hepatocellular carcinoma Mitochondrial hinge protein Immunohistochemistry
  • 相关文献

参考文献9

  • 1李悦国,耿鑫,朱国平,张维铭.肝癌病人血清蛋白质指纹图谱检测及其临床意义[J].中华肝胆外科杂志,2007,13(10):663-666. 被引量:5
  • 2Kim CH,Balny C,King TE.Role of the hinge protein in the electron transfer between cardiac cytochrome c1 and c.Equilibrium constants and kinetic probes[J].J Biol Chem,1987,262(17):8103-8108.
  • 3Wojtovich AP,Nehrke KW,Brookes PS.The mitochondrial complex II and ATP-sensitive potassium channel interaction:quantitation of the channel in heart mitochondria[J].Acta Biochim Pol,2010,57(4):431-434.
  • 4Liu AY,Abraham BA.Subtractive cloning of a hybrid human endogenous retrovirus and calbindin gene in the prostate cell line PC3[J].Cancer Res,1991,51(15):4107-4110.
  • 5Torroni A,Stepien G,Hodge JA,et al.Neoplastic transformation is associated with coordinate induction of nuclear and cytoplasmic oxidative phosphorylation genes[J].J Biol Chem,1990,265(33):20589-20593.
  • 6Liu AY,Bradner RC.Elevated expression of the human mitochondrial hinge protein gene in cancer[J].Cancer Res,1993,53(11):2460-2465.
  • 7Wachi S,Yoneda K,Wu R.Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues[J].Bioinformatics,2005,21(23):4205-4208.
  • 8Logsdon CD,Simeone DM,Binkley C,et al.Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer[J].Cancer Res,2003,63(10):2649-2657.
  • 9Wang F,Zhang R,Xia T,et al.Inhibitory effects of nitric oxide on invasion of human cancer cells[J].Cancer Lett,2007,257(2):274-282.

二级参考文献11

  • 1李悦国,张维铭.蛋白质组学在肝癌及其相关疾病研究中的应用[J].中国肿瘤临床,2005,32(16):957-960. 被引量:4
  • 2Schwegler EE, Cazares L, Steel LF, et al. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology, 2005 , 41:634-642
  • 3Paradis V, Degos F, Dargere D, et al. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology, 2005,41 : 40-47.
  • 4Roelofsen H, Balgobind R, Vonk RJ. Proteomic analysis of copper metabolism in an in vitro model of Wilson disease using surface enhanced laser desorption/ionization-time of flightmass spectrometry. J Cell Biochem, 2004,93:732-740.
  • 5Parasole R, Izzo F, Perrone F, et al. Prognostic value of serum biological markers in patients with hepatocellular carcinoma. Clin Cancer Res,2001,7:3504-3509.
  • 6Wu W, Hu W, Kavanagh JJ. Proteomics in cancer research. Int J Gynecol Cancer, 2002,12:409-423.
  • 7Lueking A, Cahill DJ, Mullner S, Protein biochips, a new and versatile platform technology for molecular medicine, Drug Discov Today, 2005,10 : 789-794.
  • 8Figeys D, Pinto D, Proteomics on a chip:promising developments, Electrophoresis, 2001, 22:208-216.
  • 9Issaq HJ, Veenstra TD, Conrads TP, et al. The SELDI-TOF MS approach to proteomics:protein profiling and biomarker identification. Biochem Biophys Res Commun, 2002, 292:587- 592.
  • 10Petricoin EF, Ardekani AM, Hitt BA,et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 2002, 359 : 572-577.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部